Literature DB >> 35759011

Intratumor and informatic heterogeneity influence meningioma molecular classification.

Abrar Choudhury1,2, Stephanie Hilz2, Stephen T Magill3, David R Raleigh4,5, Harish N Vasudevan1,2, Javier E Villanueva-Meyer6, William C Chen1,2, Calixto-Hope G Lucas7, Steve E Braunstein1, Nancy Ann Oberheim Bush2, Nicholas Butowski2,8, Melike Pekmezci7, Michael W McDermott9, Arie Perry2,7, David A Solomon7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35759011     DOI: 10.1007/s00401-022-02455-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   15.887


× No keyword cloud information.
  20 in total

1.  Topographical analysis of proliferating cells in meningiomas. Regional heterogeneity of the ability of tumors to proliferate.

Authors:  T Iuchi; N Saeki; K Osato; A Yamaura
Journal:  Neurol Res       Date:  1999-12       Impact factor: 2.448

2.  Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas.

Authors:  Cassie N Kline; Nancy M Joseph; James P Grenert; Jessica van Ziffle; Iwei Yeh; Boris C Bastian; Sabine Mueller; David A Solomon
Journal:  Neuro Oncol       Date:  2016-02-21       Impact factor: 12.300

3.  Tumor purity quantification by clonal DNA methylation signatures.

Authors:  Matteo Benelli; Dario Romagnoli; Francesca Demichelis
Journal:  Bioinformatics       Date:  2018-05-15       Impact factor: 6.937

4.  Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.

Authors:  Sybren L N Maas; Damian Stichel; Thomas Hielscher; Philipp Sievers; Anna S Berghoff; Daniel Schrimpf; Martin Sill; Philipp Euskirchen; Christina Blume; Areeba Patel; Helin Dogan; David Reuss; Hildegard Dohmen; Marco Stein; Annekathrin Reinhardt; Abigail K Suwala; Annika K Wefers; Peter Baumgarten; Franz Ricklefs; Elisabeth J Rushing; Melanie Bewerunge-Hudler; Ralf Ketter; Jens Schittenhelm; Zane Jaunmuktane; Severina Leu; Fay E A Greenway; Leslie R Bridges; Timothy Jones; Conor Grady; Jonathan Serrano; John Golfinos; Chandra Sen; Christian Mawrin; Christine Jungk; Daniel Hänggi; Manfred Westphal; Katrin Lamszus; Nima Etminan; Gerhard Jungwirth; Christel Herold-Mende; Andreas Unterberg; Patrick N Harter; Hans-Georg Wirsching; Marian C Neidert; Miriam Ratliff; Michael Platten; Matija Snuderl; Kenneth D Aldape; Sebastian Brandner; Jürgen Hench; Stephan Frank; Stefan M Pfister; David T W Jones; Guido Reifenberger; Till Acker; Wolfgang Wick; Michael Weller; Matthias Preusser; Andreas von Deimling; Felix Sahm
Journal:  J Clin Oncol       Date:  2021-10-07       Impact factor: 44.544

5.  Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.

Authors:  Stephen T Magill; Charlotte D Eaton; Abrar Choudhury; Briana C Prager; William C Chen; Martha A Cady; Kyounghee Seo; Calixto-Hope G Lucas; Tim J Casey-Clyde; Harish N Vasudevan; S John Liu; Javier E Villanueva-Meyer; Tai-Chung Lam; Jenny Kan-Suen Pu; Lai-Fung Li; Gilberto Ka-Kit Leung; Danielle L Swaney; Michael Y Zhang; Jason W Chan; Zhixin Qiu; Michael V Martin; Matthew S Susko; Steve E Braunstein; Nancy Ann Oberheim Bush; Jessica D Schulte; Nicholas Butowski; Penny K Sneed; Mitchel S Berger; Nevan J Krogan; Arie Perry; Joanna J Phillips; David A Solomon; Joseph F Costello; Michael W McDermott; Jeremy N Rich; David R Raleigh
Journal:  Nat Genet       Date:  2022-05-09       Impact factor: 41.307

6.  Advances in multidisciplinary therapy for meningiomas.

Authors:  Priscilla K Brastianos; Evanthia Galanis; Nicholas Butowski; Jason W Chan; Ian F Dunn; Roland Goldbrunner; Christel Herold-Mende; Franziska M Ippen; Christian Mawrin; Michael W McDermott; Andrew Sloan; James Snyder; Ghazaleh Tabatabai; Marcos Tatagiba; Joerg C Tonn; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Michael D Jenkinson; David R Raleigh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

7.  CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones.

Authors:  Sören Müller; Ara Cho; Siyuan J Liu; Daniel A Lim; Aaron Diaz
Journal:  Bioinformatics       Date:  2018-09-15       Impact factor: 6.937

8.  Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.

Authors:  Tareq A Juratli; Christian Thiede; Mara V A Koerner; Shilpa S Tummala; Dirk Daubner; Ganesh M Shankar; Erik A Williams; Maria Martinez-Lage; Silke Soucek; Katja Robel; Tristan Penson; Mechthild Krause; Steffen Appold; Matthias Meinhardt; Thomas Pinzer; Julie J Miller; Dietmar Krex; Heather A Ely; Ian M Silverman; Jason Christiansen; Gabriele Schackert; Hiroaki Wakimoto; Matthias Kirsch; Priscilla K Brastianos; Daniel P Cahill
Journal:  Oncotarget       Date:  2017-11-24

Review 9.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.